Patent · US Active

Kit, device and method for detecting prostate cancer

US11905565B2 · kind B2 · utility

0Cited by

0References

6Claims

0Family size

Assignees

TORAY INDUSTRIES, INC. · JP
National Cancer Center · JP

Inventors

Makiko YOSHIMOTO · Kamakura, JP
Hiroko SUDO · Kamakura, JP
Atsuko Miyano · Kamakura, JP
Satoko Kozono · Kamakura, JP
Takahiro Ochiya · Tokyo, JP
Hiroyuki Fujimoto · Amuru, UG
Fumihiko URABE · Tokyo, JP
Juntaro MATSUZAKI · Tokyo, JP

Key dates

Filing date	Nov 17, 2022
Grant date	Feb 20, 2024
Priority date	—
Expiry date	Nov 17, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/178
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

This invention provides a kit or device for detection of prostate cancer and a method for detecting prostate cancer. This invention provides a kit or device for detection of prostate cancer comprising a nucleic acid capable of specifically binding to an miRNA in a sample from a subject or a complementary strand thereof and a method for detecting prostate cancer comprising measuring the miRNA in vitro.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.